A
NYSEAGILENT TECHNOLOGIES, INC.
Technology · Laboratory Analytical Instruments
Research view
Fundamentals · SEC EDGAR · FY 2025-10-31
Revenue & Earnings — fiscal year
$6.3B
2021
$6.8B
2022
$6.8B
2023
$6.5B
2024
$6.9B
2025
Snapshot
SEC EDGAR · FY 2025-10-31Revenue$6.9B
Net Income$1.3B
Gross Profit—
Oper Income$1.5B
EPS (dil)$4.57
Rev/sh$24.60
FCF/sh$4.08
Book/sh$-0.80
Gross M—
Oper M21.3%
Profit M18.8%
FCF M16.6%
ROE-576.5%
ROA10.2%
ROIC130.0%
R&D/Rev6.5%
Rev Y/Y6.7%
Rev 3Y CAGR0.5%
EPS Y/Y3.2%
EPS 3Y CAGR3.0%
FCF 3Y CAGR4.1%
Payout22%
Div/sh$0.99
Shs Chg Y/Y-2.1%
Current Ratio1.96
Quick Ratio1.52
Debt/Eq-13.50
Int Coverage13.2×
Net Debt$1.3B
Total Debt$3.0B
Cash & Eq$1.8B
Total Assets$12.7B
Oper CF$1.6B
Capex$407.0M
Free CF$1.2B
Buybacks$425.0M
Equity$-226.0M
Liabilities$6.0B
Shs Outstand0.28B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.3B | $6.8B | $6.8B | $6.5B | $6.9B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.3B | $1.6B | $1.4B | $1.5B | $1.5B |
| Net Income | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B |
| Diluted EPS | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
| Operating Cash Flow | $1.5B | $1.3B | $1.8B | $1.8B | $1.6B |
| Free Cash Flow | $1.3B | $1.0B | $1.5B | $1.4B | $1.2B |
COMMUNITY · $A0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.